Cite
MLA Citation
Sweety Sharma et al.. “Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies.” Journal of pharmacology and pharmacotherapeutics, vol. 13, no. 4, 2022, pp. 330–340. http://access.bl.uk/ark:/81055/vdc_100178597402.0x00001b